Compare RCKY & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKY | NNNN |
|---|---|---|
| Founded | 1932 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.5M | 340.2M |
| IPO Year | 1996 | 2023 |
| Metric | RCKY | NNNN |
|---|---|---|
| Price | $45.48 | $8.08 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | 63.5K | ★ 106.7K |
| Earning Date | 04-28-2026 | 04-07-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 94.74 | N/A |
| EPS | ★ 1.99 | N/A |
| Revenue | ★ $270,408,000.00 | N/A |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $4.90 | N/A |
| P/E Ratio | ★ $23.09 | $446.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.30 | $6.61 |
| 52 Week High | $53.01 | $51.33 |
| Indicator | RCKY | NNNN |
|---|---|---|
| Relative Strength Index (RSI) | 50.70 | 35.72 |
| Support Level | $31.90 | N/A |
| Resistance Level | $48.70 | $13.01 |
| Average True Range (ATR) | 1.42 | 1.61 |
| MACD | -0.52 | -0.04 |
| Stochastic Oscillator | 16.84 | 14.54 |
Rocky Brands Inc is a designer, manufacturer, and marketer of premium footwear and apparel under brands such as Muck, XTRATUF, Rocky, Durango, Georgia Boot, Lehigh, Ranger, and the licensed brand Michelin. The company operates through three segments, with the wholesale segment generating the majority of revenue through sales of footwear and accessories to sporting goods stores, outdoor specialty stores, online retailers, marine stores, independent retailers, mass merchants, retail uniform stores, and specialty safety shoe stores. The retail segment focuses on direct-to-consumer sales through e-commerce platforms and company-operated stores, while the contract manufacturing segment includes sales to the U.S. military, private label production, and sourcing arrangements for customers.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).